文献速递头颈部肿瘤放疗放疗物理与技术

基于ADC变化早期预测鼻咽癌放疗中腮腺分泌功能:II期前瞻性研究

Early prediction of parotid glands secretory function based on ADC variations during radiotherapy for nasopharyngeal carcinoma: a phase II prospective study.
PubMed 文献 · Radiat Oncol · 2025-07-25

该II期前瞻性研究纳入80例接受根治性放化疗的鼻咽癌患者,在放疗前、第5次、第15次分次及放疗结束时行MR-DWI,记录同侧与对侧腮腺ADC值和体积,并用唾液腺闪烁显像和RTOG口干标准评估唾液功能。结果显示从放疗前到第5次分次,平均ADC值显著升高(同侧17.7%,对侧16.3%,p<0.01),而体积变化最小;ΔADC5与放疗后6个月口干发生率正相关,且是多变量分析中分泌功能障碍的独立预测因子,而非ΔrV5。

要点

  • 鼻咽癌放疗第5次分次时腮腺ADC值已显著升高,早于体积明显变化。
  • ΔADC5是放疗后6个月腮腺分泌功能障碍的独立预测因子。
  • ADC变化与 delivered dose 及腮腺体积缩小正相关。

核心结论

  • ΔADC5可在腮腺体积发生显著变化之前预测放射性腮腺损伤,从而为早期干预提供机会。

研究设计与样本

  • II期前瞻性研究,纳入接受根治性放化疗的鼻咽癌患者,放疗前、第5次、第15次分次及放疗结束时行MR-DWI,评估腮腺ADC值、体积及唾液功能。

主要发现

  • 从放疗前到放疗结束,ADC值变化与 delivered dose 正相关(p<0.01),与腮腺体积缩小正相关(p<0.01)。
  • 从放疗前到第5次分次,平均ADC值同侧升高17.7%、对侧升高16.3%(p<0.01),而体积变化最小(同侧p=0.060,对侧p=0.068)。
  • ΔADC5与放疗后6个月口干发生率正相关(p<0.01)。
  • 多变量分析显示ΔADC5而非ΔrV5是分泌功能障碍的独立预测因子:同侧SGS OR=1.010(p=0.015)、RTOG OR=1.026(p=0.000);对侧SGS OR=1.017(p=0.004)、RTOG OR=1.015(p=0.002)。

临床怎么用

  • 可利用放疗第5次分次时的腮腺ADC变化早期识别分泌功能障碍高风险患者,在体积显著变化前考虑干预。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: This study aimed to quantify dynamic changes in the Apparent Diffusion Coefficient (ADC) values of the parotid glands during radiotherapy and explore their correlation with early-stage gland dysfunction. METHODS: Nasopharyngeal carcinoma patients receiving definitive chemoradiotherapy were prospectively enrolled. Magnetic Resonance Diffusion-Weighted Imaging (MR-DWI) was performed at pre-radiotherapy (pre-RT), the 5th, 15th fractions, and end of radiotherapy. ADC values and volumes for ipsilateral (IP) and contralateral parotid glands (CP) were recorded. Salivary function was assessed using scintigraphy (SGS) and the Radiation Therapy Oncology Group (RTOG) xerostomia criteria. RESULTS: A total of 80 eligible patients were analyzed. From pre-radiotherapy(pre-RT) to the end of radiotherapy, Pearson correlation analysis showed that changes in ADC values were positively correlated with the delivered dose (p < 0.01) and reduction in parotid volume (p < 0.01).From pre-RT to the 5th fraction, mean ADC values((ΔADC5) increased significantly by 17.7% (IP) and 16.3% (CP) (p < 0.01), with minimal volume changes(ΔrV5) (p = 0.060, p = 0.068). Spearman analysis revealed a positive association between the change in ΔADC5 and the incidence of xerostomia 6 months after radiotherapy (p < 0.01). Multivariable analysis identified ΔADC5 rather than ΔrV5 as an independent predictor of secretory dysfunction (IP: Odds Ratio (OR) = 1.010, p = 0.015 by SGS; OR = 1.026, p = 0.000 by RTOG; CP: OR = 1.017, p = 0.004 by SGS; OR = 1.015, p = 0.002 by RTOG). CONCLUSION: This study analyze the dynamic changes in parotid gland ADC values, volume, and secretion function throughout radiotherapy. Changes in ΔADC5 can predict radiation-induced parotid gland injury before significant volume changes occur, thereby enabling early intervention.

来源:Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Wang H, Fan M, Yan L, et al. Early prediction of parotid glands secretory function based on ADC variations during radiotherapy for nasopharyngeal carcinoma: a phase II prospective study. Radiat Oncol. 2025. PMID: 40713788. doi:10.1186/s13014-025-02696-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。